CERS

Cerus Corp

3.16

Jul 02 • 04:00PM ET +0.16 (5.33%)

Healthcare Medical Devices USA Small NASD

Peers: BSX EW MDT MASI ICUI MMSI BAX BDX TFX RMD

| Held by: ARKK ARKG VTI IWM VXF IWO FESM SMLF VTWO SCHA

Scroll to Statements

Index	RUT
Market Cap	633.17M
Enterprise Value	650.84M
Income	-9.55M
Sales	216.56M
Book/sh	0.34
Cash/sh	0.40
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	275
IPO	Jan 31, 1997

P/E	-
Forward P/E	-
PEG	-
P/S	2.92
P/B	9.37
P/C	7.87
P/FCF	-
EV/EBITDA	-
EV/Sales	3.01
Quick Ratio	1.06
Current Ratio	1.63
Debt/Eq	1.44
LT Debt/Eq	0.62
Option/Short	Yes / Yes

EPS (ttm)	-0.05
EPS next Y	-0.00
EPS next Q	-0.01
EPS this Y	58.33%
EPS next Y	90.00%
EPS next 5Y	-
EPS past 3/5Y	30.31% 25.82%
Sales past 3/5Y	8.35% 17.53%
EPS Y/Y TTM	51.23%
Sales Y/Y TTM	16.97%
EPS Q/Q	79.61%
Sales Q/Q	24.10%
Earnings	Apr 30 AMC
EPS/Sales Surpr.	75.00% 7.58%

Insider Own	3.62%
Insider Trans	-17.73%
Inst Own	74.17%
Inst Trans	-1.57%
ROA	-4.45%
ROE	-15.52%
ROIC	-8.73%
Gross Margin	52.99%
Oper. Margin	-14.53%
Profit Margin	-4.41%
SMA20	16.33%
SMA50	22.11%
SMA200	51.81%
Trades

Shs Outstand	200.32M
Shs Float	193.12M
Short Float	10.20%
Short Ratio	7.80
Short Interest	19.70M
52W High	3.15 0.32%
52W Low	1.15 174.78%
Volatility	5.89% 6.22%
ATR (14)	0.18
RSI (14)	69.23
Beta	1.78
Rel Volume	1.30
Avg Volume	2.53M
Volume	3,286,641

Perf Week	10.49%
Perf Month	17.04%
Perf Quarter	68.98%
Perf Half Y	51.20%
Perf YTD	53.40%
Perf Year	102.56%
Perf 3Y	28.46%
Perf 5Y	-43.67%
Perf 10Y	-49.60%
Recom	1.00
Target Price	4.67
Prev Close	3.00
Price	3.16
Change	5.33%

Date	Action	Analyst	Rating Change	Price Target Change
May-01-26	Upgrade	BTIG Research	Neutral → Buy	$4
Apr-12-24	Initiated	Craig Hallum	Buy	$5
Jan-20-23	Downgrade	BTIG Research	Buy → Neutral
Jan-17-23	Downgrade	Stephens	Overweight → Equal-Weight	$3.75
Oct-08-20	Resumed	BTIG Research	Buy	$9
Jun-16-20	Resumed	Cantor Fitzgerald	Overweight	$9
Feb-26-20	Initiated	BTIG Research	Buy	$7
Nov-13-19	Upgrade	BTIG Research	Neutral → Buy	$7
Aug-28-19	Initiated	Stifel	Buy
Aug-23-19	Resumed	Stephens	Overweight
Jan-05-18	Resumed	Cantor Fitzgerald	Overweight
Dec-08-17	Resumed	BTIG Research	Neutral
Jul-07-16	Resumed	Cantor Fitzgerald	Buy	$9
Dec-17-15	Downgrade	Wedbush	Outperform → Neutral
May-02-14	Reiterated	MLV & Co	Buy	$8.50 → $6
Apr-24-13	Reiterated	Cantor Fitzgerald	Buy	$5.50 → $6
Mar-15-13	Reiterated	MLV & Co	Buy	$7.50 → $8.50
Apr-17-12	Initiated	Cantor Fitzgerald	Buy	$5.50
Feb-29-12	Upgrade	Robert W. Baird	Neutral → Outperform	$3 → $6
Nov-10-11	Reiterated	MLV & Co	Buy	$4 → $5

Show Previous Ratings

Jun-17-26 08:30AM	Cerus to Showcase New Evidence, Innovation and Global Experience with the INTERCEPT Blood System at the 39th International ISBT Congress (Business Wire)
Jun-08-26 08:30AM	Cerus Corporation Closes New Debt Facility of Up to $110 Million (Business Wire)
May-27-26 11:35AM	Bradley L. Radoff Announces Intent to Withhold Votes from Chair and CEO William Greenman and Director Ann Lucena (Business Wire)
May-15-26 11:06AM	Cerebras IPO in focus as Nvidia earnings loom (Yahoo Finance Video) -6.77%
May-01-26 08:30AM	Cerus Corporation Q1 2026 Earnings Call Summary (Moby) +33.99%
03:17AM	Loading…
03:17AM	Cerus Corp (CERS) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
Apr-30-26 04:19PM	Cerus: Q1 Earnings Snapshot (Associated Press) +5.73%
04:01PM	Cerus Corporation Announces First Quarter 2026 Financial Results (Business Wire)
Apr-27-26 08:00AM	Cerus Corporation Announces New, Four-Year Supply Agreement with French Blood Establishment for INTERCEPT Blood System (Business Wire)
Apr-16-26 04:01PM	Cerus Corporation to Release First Quarter 2026 Financial Results on April 30, 2026 (Business Wire)
Mar-16-26 04:05PM	Cerus Appoints Vivek Jayaraman as President and Chief Executive Officer (Business Wire) +6.51%
Mar-10-26 07:30AM	Cathie Wood Bets $19 Million on 5 Beaten-Down Stocks (Barchart) -8.29%
Mar-07-26 10:05PM	Cerus Details INTERCEPT Growth Plan, BCA Deal Upside and 2026 RBC Milestones at TD Cowen Conference (MarketBeat)
Mar-03-26 08:30AM	Cerus Corporation Q4 2025 Earnings Call Summary (Moby) -15.81%
12:02AM	Cerus Corp (CERS) Q4 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ... (GuruFocus.com)
06:27PM	Loading…
Mar-02-26 06:27PM	Cerus Q4 Earnings Call Highlights (MarketBeat)
04:15PM	Cerus: Q4 Earnings Snapshot (Associated Press Finance)
04:01PM	Cerus Corporation Announces Full-Year and Fourth Quarter 2025 Financial Results (Business Wire)
Feb-20-26 08:30AM	Cerus Corporation to Participate in the TD Cowen 46th Annual Health Care Conference (Business Wire) -5.86%
Feb-17-26 04:01PM	Cerus Corporation to Release Fourth Quarter and Full-Year 2025 Financial Results on March 2, 2026 (Business Wire) +5.80%
Jan-22-26 07:30AM	DRK Blood Donation Service Baden-Wurttemberg - Hessen Starts INITIATE Study to Evaluate Pathogen-Inactivated Platelet Concentrates Treated with Cerus' INTERCEPT Blood System in Routine Clinical Practice (Business Wire)
Jan-11-26 04:00PM	Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2025 Product Revenue and Provides Outlook (Business Wire)
Dec-27-25 07:43AM	TD Cowen Sees Compelling Long-Term Value in Cerus Corporation (CERS) (Insider Monkey)
Dec-10-25 04:15PM	Cerus Corporation Announces Group Purchasing Agreement with Blood Centers of America (Business Wire) +13.76%
Nov-07-25 12:01AM	Cerus Corp (CERS) Q3 2025 Earnings Call Highlights: Record Revenue and Strategic Shifts Amid ... (GuruFocus.com) +21.28%
Nov-06-25 05:07PM	Cerus: Q3 Earnings Snapshot (Associated Press Finance)
04:01PM	Cerus Corporation Announces Record Results for Third Quarter 2025 and Raises Full Year 2025 Product Revenue Guidance (Business Wire)
Oct-21-25 08:30AM	Cerus Corporation Announces Abstracts and Industry Workshop on IFC at the 2025 AABB Annual Meeting (Business Wire)
Oct-16-25 04:00PM	Cerus Corporation to Release Third Quarter 2025 Financial Results on November 6, 2025 (Business Wire)
Aug-25-25 09:00AM	The German National Blood Advisory Committee Issues Formal Recommendation for Improving the Safety of Platelet Transfusions (Business Wire)
08:30AM	Loading…
Aug-21-25 08:30AM	Cerus Corporation to Participate in the Cantor Global Healthcare Conference 2025 (Business Wire)
Aug-05-25 05:04PM	Cerus: Q2 Earnings Snapshot (Associated Press Finance)
04:01PM	Cerus Corporation Announces Second Quarter 2025 Financial Results (Business Wire)
Aug-04-25 10:06AM	Cerus Corp (CERS) Q2 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Jul-22-25 04:15PM	Cerus Corporation to Release Second Quarter 2025 Financial Results on August 5, 2025 (Business Wire)
Jul-21-25 08:30AM	Cerus Corporation Announces Additional Department of Defense Award to Advance Care for Major Hemorrhage in Traumatic Injury (Business Wire)
Jul-02-25 08:30AM	Cerus Corporation Provides INTERCEPT Red Blood Cell CE Mark Application Update (Business Wire) +5.41%
Jun-13-25 04:01PM	Cerus Corporation Celebrates World Blood Donor Day 2025 (Business Wire) +6.82%
Jun-03-25 04:30PM	Cerus Corporation to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference 2025 (Business Wire) +9.09%
May-29-25 08:30AM	Cerus Corporation Presents Clinical Data for INTERCEPT Blood System at the 35th Regional International Society of Blood Transfusion Congress in Milan (Business Wire)
May-28-25 08:30AM	Cerus Corporation Announces Multiple In-Country Regulatory Approvals for INT200 Next-Generation INTERCEPT Illumination Device (Business Wire)
May-01-25 08:26PM	Cerus Corporation (CERS) Q1 2025 Earnings Call Transcript (Seeking Alpha)
05:05PM	Cerus (CERS) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:07PM	Cerus: Q1 Earnings Snapshot (Associated Press Finance)
04:00PM	Cerus Corporation Announces First Quarter 2025 Financial Results (Business Wire)
Apr-17-25 08:30AM	Cerus Corporation to Release First Quarter 2025 Financial Results on May 1, 2025 (Business Wire)
Mar-06-25 11:44AM	Cerus secures CE mark approval for LED-based illumination device (Medical Device Network)
Mar-05-25 01:00PM	Cerus Corporation Announces Receipt of CE Mark for Next-Generation INTERCEPT Illumination Device (INT200) (Business Wire)
Feb-21-25 02:14AM	Cerus Corp (CERS) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Positive Cash Flow (GuruFocus.com) -5.17%
Feb-20-25 04:20PM	Cerus: Q4 Earnings Snapshot (Associated Press Finance)
04:00PM	Cerus Corporation Announces Full-Year and Fourth Quarter 2024 Financial Results (Business Wire)
09:27AM	What To Expect From Cerus Corp (CERS) Q4 2024 Earnings (GuruFocus.com)
Feb-19-25 04:00PM	Cerus Corporation to Participate in the TD Cowen 45th Annual Health Care Conference (Business Wire)
Feb-07-25 08:30AM	Cerus Corporation to Release Fourth Quarter and Full-Year 2024 Financial Results on February 20, 2025 (Business Wire)
Jan-13-25 08:30AM	Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2024 Product Revenue and Provides Business Update (Business Wire) +5.70%
Nov-13-24 08:30AM	Cerus Corporation to Participate in Upcoming Investor Conferences (Business Wire)
Oct-31-24 02:11PM	Q3 2024 Cerus Corp Earnings Call (Thomson Reuters StreetEvents) -8.72%
05:01AM	Cerus Corp (CERS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
Oct-30-24 05:10PM	Cerus (CERS) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
04:06PM	Cerus: Q3 Earnings Snapshot (Associated Press Finance)
04:00PM	Cerus Corporation Announces Third Quarter 2024 Financial Results (Business Wire)
Oct-29-24 09:16AM	Cerus Corp (CERS) Q3 2024 Earnings Report Preview: What To Expect (GuruFocus.com)
Oct-18-24 08:30AM	Cerus Corporation to Release Third Quarter 2024 Financial Results on October 30, 2024 (Business Wire)
08:30AM	Cerus Corporation Announces Workshop and Abstracts at the 2024 AABB Annual Meeting (Business Wire)
08:25AM	Cerus price target lowered to $3 from $6 at Stifel (TipRanks)
Oct-16-24 04:00PM	Cerus Corporation Provides Updates on INTERCEPT Red Blood Cell Programs in the U.S. and Europe (Business Wire) -9.44%
Oct-09-24 03:49PM	Cerus Corp (CERS) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Positive EBITDA (GuruFocus.com) +8.72%
Sep-06-24 01:47AM	Insider Selling: CFO Kevin Green Sells 82,657 Shares of Cerus Corp (CERS) (GuruFocus.com)
Aug-01-24 05:10PM	Cerus (CERS) Reports Q2 Loss, Tops Revenue Estimates (Zacks) -9.73% +14.95%
04:07PM	Cerus: Q2 Earnings Snapshot (Associated Press Finance)
04:00PM	Cerus Corporation Announces Second Quarter 2024 Financial Results and Increases Full-Year 2024 Product Revenue Guidance Range (Business Wire)
Jul-18-24 08:30AM	Cerus Corporation to Release Second Quarter 2024 Financial Results on August 1, 2024 (Business Wire) -6.36%
Jul-02-24 04:00PM	Cerus Corporation Announces Appointment of Dean Gregory to Board of Directors (Business Wire)
Jun-21-24 08:30AM	Cerus Corporation Announces Symposium and Abstracts at the 38th International Congress of the International Society of Blood Transfusion (Business Wire)
Jun-14-24 08:30AM	Cerus Corporation Celebrates World Blood Donor Day 2024 (Business Wire)
May-22-24 08:30AM	Cerus Corporation to Participate in 21st Annual Craig-Hallum Institutional Investor Conference (Business Wire)
May-03-24 10:40AM	Cerus Corporation (NASDAQ:CERS) Q1 2024 Earnings Call Transcript (Insider Monkey) -7.95%
06:48AM	Q1 2024 Cerus Corp Earnings Call (Thomson Reuters StreetEvents)
03:58AM	Cerus Corp (CERS) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ... (GuruFocus.com)
May-02-24 08:59PM	CERS Stock Earnings: Cerus Meets EPS, Misses Revenue for Q1 2024 (InvestorPlace)
06:04PM	Cerus Corp (CERS) Q1 2024 Earnings: Revenue Surpasses Estimates, Net Loss Narrows (GuruFocus.com)
04:04PM	Cerus: Q1 Earnings Snapshot (Associated Press Finance)
04:00PM	Cerus Corporation Announces First Quarter 2024 Financial Results (Business Wire)
Apr-18-24 08:30AM	Cerus Corporation to Release First Quarter 2024 Financial Results on May 2, 2024 (Business Wire)
Mar-26-24 08:30AM	Cerus Corporation Announces FDA Approval of Extended Shelf Life for INTERCEPT Platelet Processing Sets Doubling Previous Shelf Life (Business Wire)
Mar-19-24 08:00AM	Cerus Corporation Announces Positive Topline Results for the Phase 3 Clinical Trial of the INTERCEPT Blood System for Red Blood Cells in Cardiovascular Surgery Patients (Business Wire) +9.68%
Mar-15-24 01:49AM	Insider Sell: President and CEO William Greenman Sells 125,926 Shares of Cerus Corp (CERS) (GuruFocus.com)
01:48AM	Insider Sell: COO Vivek Jayaraman Sells 53,041 Shares of Cerus Corp (CERS) (GuruFocus.com)
Mar-07-24 01:40PM	Cerus Corp (CERS) Posts Narrowed Q4 Net Loss and Achieves Adjusted EBITDA Breakeven (GuruFocus.com)
11:46AM	Cerus Corporation (NASDAQ:CERS) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-06-24 06:23AM	Q4 2023 Cerus Corp Earnings Call (Thomson Reuters StreetEvents) +21.61%
Mar-05-24 09:53PM	CERS Stock Earnings: Cerus Beats EPS, Misses Revenue for Q4 2023 (InvestorPlace) -6.13%
04:26PM	Cerus: Q4 Earnings Snapshot (Associated Press Finance)
04:00PM	Cerus Corporation Announces Fourth Quarter and Full-Year 2023 Financial Results (Business Wire)
Feb-23-24 11:56AM	12 Best Rising Penny Stocks To Buy (Insider Monkey)
Feb-20-24 08:30AM	Cerus Corporation to Release Fourth Quarter and Full-Year 2023 Financial Results on March 5, 2024 (Business Wire)
Feb-01-24 08:30AM	Cerus Corporation to Participate in Upcoming Investor Conferences (Business Wire) +8.84%
Jan-15-24 09:30AM	3 Growth Stocks That Could Go Parabolic in 2024 (Motley Fool)
Jan-08-24 08:30AM	Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2023 Product Revenue and Provides Business Update (Business Wire) +5.61%
Nov-03-23 09:19AM	Cerus Corporation (NASDAQ:CERS) Q3 2023 Earnings Call Transcript (Insider Monkey) +8.81%

Cerus Corp. engages in the research, development, and manufacturing of biomedical and surgical products. The firm produces blood system for platelets and plasma. It operates through Blood Safety segment. It markets products under the INTERCEPT brand. The company was founded by Laurence M. Corash and John E. Hearst on September 19, 1991 and is headquartered in Concord, CA.

PresidentMr. William M. Greenman

VP of Finance & CFOMr. Kevin D. Green CPA

Chief Operating OfficerMr. Vivek K. Jayaraman

Chief Legal OfficerMs. Chrystal N. Jensen J.D.

Ph.D.Dr. Richard J. Benjamin MBChB

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Green Kevin Dennis	Chief Financial Officer	Jun 30 '26	Sale	2.94	33,676	99,105	1,062,188	Jul 02 07:19 PM
Jayaraman Vivek K	Chief Operating Officer	Jun 30 '26	Sale	2.94	42,359	124,658	1,694,348	Jul 02 07:18 PM
Jensen Chrystal	Chief Legal Officer	Jun 30 '26	Sale	2.94	24,329	71,598	966,657	Jul 02 07:15 PM
Greenman William Mariner	President and CEO	Jun 30 '26	Sale	2.94	101,919	299,937	5,053,036	Jul 02 07:13 PM
BJERKHOLT ERIC	Director	Jun 09 '26	Sale	2.60	20,454	53,180	261,679	Jun 11 09:17 PM
ERIC BJERKHOLT	Director	Jun 09 '26	Proposed Sale	2.60	20,454	53,180		Jun 09 04:12 PM
Jayaraman Vivek K	Chief Operating Officer	May 29 '26	Sale	3.00	16,667	50,001	1,656,707	Jun 02 07:46 PM
VIVEK K JAYARAMAN	Officer	May 29 '26	Proposed Sale	3.00	16,667	50,001		May 29 04:13 PM
Jayaraman Vivek K	Chief Operating Officer	May 01 '26	Sale	3.00	16,667	50,001	1,673,374	May 05 06:31 PM
RICHARD J BENJAMIN	Officer	May 01 '26	Proposed Sale	2.82	76,209	214,627		May 01 04:08 PM
VIVEK K JAYARAMAN	Officer	May 01 '26	Proposed Sale	3.00	16,667	50,001		May 01 04:07 PM
Jayaraman Vivek K	Chief Operating Officer	Mar 12 '26	Sale	1.66	165,200	273,769	1,747,674	Mar 16 07:44 PM
Greenman William Mariner	President and CEO	Mar 12 '26	Sale	1.66	447,757	742,023	4,998,493	Mar 16 07:44 PM
Green Kevin Dennis	Chief Financial Officer	Mar 12 '26	Sale	1.66	127,544	211,366	1,040,551	Mar 16 07:44 PM
Benjamin Richard J	Chief Medical Officer	Mar 12 '26	Sale	1.66	101,740	168,604	777,361	Mar 16 07:43 PM
Green Kevin Dennis	Chief Financial Officer	Mar 05 '26	Sale	2.06	55,225	113,902	1,195,891	Mar 09 09:56 PM
Green Kevin Dennis	Chief Financial Officer	Mar 06 '26	Sale	2.01	27,796	55,745	1,168,095	Mar 09 09:56 PM
Benjamin Richard J	Chief Medical Officer	Mar 05 '26	Sale	2.06	61,233	126,305	943,762	Mar 09 09:35 PM
Benjamin Richard J	Chief Medical Officer	Mar 09 '26	Sale	1.88	40,426	76,029	879,101	Mar 09 09:35 PM
Benjamin Richard J	Chief Medical Officer	Mar 06 '26	Sale	2.01	24,235	48,603	919,527	Mar 09 09:35 PM
Jensen Chrystal	Chief Legal Officer	Mar 06 '26	Sale	2.01	30,845	61,860	1,059,139	Mar 09 09:31 PM
Jayaraman Vivek K	Chief Operating Officer	Mar 06 '26	Sale	2.01	34,094	68,376	1,912,874	Mar 09 09:30 PM
Greenman William Mariner	President and CEO	Mar 06 '26	Sale	2.01	78,187	156,804	5,446,250	Mar 09 09:28 PM
RICHARD J BENJAMIN	Officer	Mar 09 '26	Proposed Sale	1.88	40,426	76,029		Mar 09 04:09 PM
KEVIN D GREEN	Officer	Mar 05 '26	Proposed Sale	2.06	55,225	113,902		Mar 05 05:03 PM
RICHARD J BENJAMIN	Officer	Mar 05 '26	Proposed Sale	2.06	61,233	126,299		Mar 05 05:00 PM
Jensen Chrystal	Chief Legal Officer	Nov 24 '25	Sale	1.70	55,000	93,500	728,294	Nov 26 04:07 PM
CHRYSTAL NIKOLE JENSEN	Officer	Nov 24 '25	Proposed Sale	1.70	55,000	93,500		Nov 24 05:17 PM
Gregory Dean A.	Director	Aug 25 '25	Buy	1.25	25,000	31,250	86,725	Aug 25 03:25 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

$100 Off Your First Year Get Elite For Just $199.50

CERS

Cerus Corp

Upgrade your Finviz experience